Viekira Pak ombitasvir/paritaprevir/ritonavir plus dasabuvir regulatory update

The U.S. label for AbbVie’s HCV therapy Viekira Pak now includes a contraindication for patients with decompensated cirrhosis Child-Pugh class B and C. The label previously did not recommend Viekira f...